Mohammad H. Kazeroun

Mohammad Kazeroun leverages his background in evolutionary and computational biology to investigate cancer evolution through tumor cell phylogeny. His research focuses on intra-tumoral heterogeneity and subclonal growth, which contribute to drug resistance in cancers like Multiple Myeloma. As part of the Oxford Translational Myeloma Centre (OTMC), he works to unravel the genomic complexity of myeloma. Mohammad co-developed the Myeloma Genome Project Panel (MGPP), a comprehensive targeted genomics panel for myeloma profiling, and is currently developing a pipeline to integrate this approach into standard NHS clinical practice. His expertise lies in analysing Whole Genome Sequencing (WGS) and multi-omics data to identify copy number aberrations, translocations, and single-nucleotide variant (SNV) mutations for genomic profiling, enabling risk assessment, diagnosis, and prognosis for patients.